Simeon I Taylor, MD

Trials

Studies that name Simeon I Taylor, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:57 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT06813014 · Pharmacogenetics of Response to Sitagliptin (PRS)

  University of Maryland, Baltimore · not yet recruiting · Diabetes · principal investigator
• Ph1
  NCT05762744 · Pharmacogenomics of GLP1 Receptor Agonists

  University of Maryland, Baltimore · terminated · Type 2 Diabetes · principal investigator
• Ph1
  NCT02891954 · Genetics of Response to Canagliflozin

  University of Maryland, Baltimore · active not recruiting · Diabetes Mellitus, Type 2 · principal investigator
• Ph4
  NCT02462421 · Pharmacogenetics of SGLT2 Inhibitors

  University of Maryland, Baltimore · terminated · Diabetes Mellitus, Gout, Hyperuricemia · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Genetics of Response to Canagliflozin
  R01DK118942 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI AMBER L BEITELSHEES, SIMEON I. TAYLOR · fiscal years 2018 to 2022
  Named on NCT02891954
• Pharmacogenomics of SGLT2 inhibitors: Pilot & Feasibility Study
  R21DK105401 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SIMEON I. TAYLOR · fiscal years 2015 to 2016
  Named on NCT02462421